Idaliz Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -53.94%
- Profit Growth -78.81%
- Ebitda -74.03%
- Net Worth 7.44%
- Total Assets -1.59%
About Idaliz Healthcare
Idaliz Healthcare Private Limited (IHPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 June 2014 and has a history of Ten years and seven months. Its registered office is in Cachar, Assam, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Jhumi Mitra, Momi Debnath, and Sambuddha Dhar serve as directors at the Company.
Company Details
-
Location
Cachar, Assam, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110AS2014PTC011886
-
Company No.
011886
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jun 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
What products or services does Idaliz Healthcare Private Limited offer?
Idaliz Healthcare Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Common Disease Medicines, Antihistamines, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Idaliz Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jhumi Mitra
|
Director | 24-Jun-2014 | Current |
|
Momi Debnath
|
Director | 24-Jun-2014 | Current |
|
Sambuddha Dhar
|
Director | 30-Aug-2022 | Current |
Financial Performance of Idaliz Healthcare.
Idaliz Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 53.94% decrease. The company also saw a substantial fall in profitability, with a 78.81% decrease in profit. The company's net worth moved up by a moderate rise of 7.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Idaliz Healthcare?
In 2017, Idaliz Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Idaliz Healthcare?
Unlock and access historical data on people associated with Idaliz Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Idaliz Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Idaliz Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.